Comparison between [
[68Ga]Ga-PSMA-617
positron emission tomography imaging of glioblastoma
recurrent glioblastoma
theranostics for glioblastoma
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Nov 2023
11 Nov 2023
Historique:
received:
10
10
2023
revised:
08
11
2023
accepted:
09
11
2023
medline:
27
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
The aim of this prospective clinical study was to evaluate the potential of the prostate specific membrane antigen (PSMA) targeting ligand, [
Identifiants
pubmed: 38003399
pii: ijms242216208
doi: 10.3390/ijms242216208
pmc: PMC10671181
pii:
doi:
Substances chimiques
PSMA-617
0
Gallium Radioisotopes
0
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : The Rotary Club of Rockhampton North
ID : N/A
Organisme : GenesisCare Newcastle
ID : N/A
Organisme : National Health and Medical Research Council
ID : APP1132471
Organisme : National Health and Medical Research Council
ID : APP1194004
Organisme : National Health and Medical Research Council
ID : 2017140
Organisme : MHF Centre for Brain Cancer Research at the University of Newcastle
ID : N/A
Organisme : CSIRO Probing Biosystems Future Science Platform
ID : N/A
Organisme : Cancer Institute of New South Wales
ID : 2019/ECF1015
Références
Neurosurgery. 2005 Sep;57(3):505-11; discussion 505-11
pubmed: 16145529
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4252-4261
pubmed: 34773473
Nucl Med Biol. 2010 Oct;37(7):727-40
pubmed: 20870148
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Arch Pathol Lab Med. 2011 Nov;135(11):1486-9
pubmed: 22032578
Nucl Med Biol. 2006 Apr;33(3):287-94
pubmed: 16631076
J Nucl Med. 2015 Nov;56(11):1697-705
pubmed: 26294298
Cancer Res. 1999 Jul 1;59(13):3192-8
pubmed: 10397265
PET Clin. 2013 Apr;8(2):129-46
pubmed: 27157944
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):170-1
pubmed: 25293865
Clin Nucl Med. 2020 Jan;45(1):11-18
pubmed: 31663868
Neurotherapeutics. 2009 Jul;6(3):447-57
pubmed: 19560735
Nat Rev Neurosci. 2007 Aug;8(8):610-22
pubmed: 17643088
EJNMMI Res. 2017 Aug 16;7(1):64
pubmed: 28815478
Clin Cancer Res. 1997 Jan;3(1):81-5
pubmed: 9815541
EJNMMI Phys. 2022 Feb 5;9(1):9
pubmed: 35122529
Eur Radiol. 2011 Nov;21(11):2417-24
pubmed: 21796499
Clin Nucl Med. 2017 Jan;42(1):e41-e48
pubmed: 27846000
Cancer Cell Int. 2014 Mar 20;14(1):26
pubmed: 24645697
J Digit Imaging. 2018 Jun;31(3):290-303
pubmed: 29181613
Adv Biomed Res. 2019 Feb 27;8:18
pubmed: 30993088
J Nucl Med. 2014 Oct;55(10):1611-6
pubmed: 25125481
Sci Rep. 2018 May 8;8(1):7201
pubmed: 29740097
J Nucl Med. 2023 Jul;64(7):1024-1029
pubmed: 36997329
Clin Nucl Med. 2018 Sep;43(9):e304-e309
pubmed: 29939953
Iran J Pathol. 2018 Winter;13(1):45-53
pubmed: 29731795
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1605-1606
pubmed: 32040612
Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1464-70
pubmed: 15248032
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
J Pers Med. 2021 Jun 30;11(7):
pubmed: 34209106
J Stat Softw. 2018 Aug;86:
pubmed: 30288153
J Neurooncol. 2009 May;92(3):317-35
pubmed: 19357959
Front Neuroinform. 2013 Dec 30;7:45
pubmed: 24416015